Novo Nordisk India Plans To Triple Staff Size In Four Years
This article was originally published in PharmAsia News
Executive Summary
Novo Nordisk India plans to expand its business in India by tripling its staff in four years and strengthening partnerships with Indian drug makers. The firm says the move is part of an effort to build its diabetes business. Novo Nordisk has joined with India's Torrent Pharma to provide strength in discovering and manufacturing new diabetes drugs. The firm now has more than 600 employees in India, but it wants to be a leader in the insulin business in a country that is considered the biggest for diabetes care. (Click here for more